Source: PMLiVE

TIB Molbiol: Roche acquires test maker TIB Molbiol

The Swiss biopharmaceutical group has acquired the Berlin-based diagnostics biotech after two decades of collaboration, expanding its PCR test portfolio

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Olfert Landt's photo - Founder & CEO of TIB Molbiol

Founder & CEO

Olfert Landt

CEO Approval Rating

90/100

Read more